A carregar...
LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial
Abstract Background Cachexia is a formidable clinical challenge in pancreatic cancer. We assessed LY2495655 (antimyostatin antibody) plus standard‐of‐care chemotherapy in pancreatic cancer using cachexia status as a stratifier. Methods In this randomized, phase 2 trial, patients with stage II–IV pan...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley
2018-10-01
|
| Colecção: | Journal of Cachexia, Sarcopenia and Muscle |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1002/jcsm.12331 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|